SEATTLE, Feb. 26, 2013 /PRNewswire/ -- Cell Therapeutics, Inc.'s (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its fourth quarter and full year 2012 financial results on Thursday, February 28, 2013, after the close of the U.S. financial markets. Following the announcement, members of the management team will host a webcast conference call to discuss the results and provide a general corporate update, at 4:30 p.m. ET ( 1:30 p.m. PT). Access to the event can be obtained as follows:
Thursday, February 28th 1:30 p.m. PT/ 4:30 p.m. ET/ 10:30 p.m. CET1-877-941-6009 (domestic) +1 480-629-9819 (international)
To access the live audio webcast or the subsequent archived recording, visit CTI's website, www.celltherapeutics.com. Webcast and telephone replays of the conference call will be available at approximately two hours after completion of the call. Callers can access the replay by dialing 1-800-406-7325 (domestic) or +1 303-590-3030 (international). The access code for the replay is 4603217#. The webcast will be recorded and available for replay on CTI's website until April 30, 2013.
About Cell Therapeutics, Inc.Cell Therapeutics (NASDAQ and MTA: CTIC) is a biopharmaceutical company committed to the development and commercialization of an integrated portfolio of oncology products aimed at making cancer more treatable. CTI is headquartered in Seattle, WA. For additional information and to sign up for email alerts and get RSS feeds, please visit the company's website at www.CellTherapeutics.com. Contacts: Monique Greer +1 206.272.4343 firstname.lastname@example.org Ed Bell+1 206.282.7100 email@example.com SOURCE Cell Therapeutics, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts